A drug widely used for anesthesia and sedation in patients with subarachnoid hemorrhage, a life-threatening form of stroke mostly caused by an aneurysm rupture, could have other potential benefits such as helping to protect against a secondary brain injury in those patients, UF researchers reported in a comprehensive review of preclinical and clinical studies in the Journal of Neurosurgical Anesthesiology.
The review, led by Sylvain Doré, Ph.D., a professor of anesthesiology; Katharina Busl, M.D., an associate professor of neurology; and Hongtao Liu, M.D., a visiting scientist in Doré’s lab, concluded that the drug dexmedetomidine shows promise to serve as a protective therapy for patients with subarachnoid hemorrhage, known as SAH.
from Department of Neurology » College of Medicine » University of Florida https://ift.tt/3j3nroL
Comments
Post a Comment